A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Study Director
Takeda
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St George Private Hospital
Kogarah, New South Wales, Australia
Shir-Jing HoRecruiting - Townsville Hospital
Douglas, Queensland, Australia
Hock-Choong LaiRecruiting - Western Health - Sunshine Hospital
St Albans, Victoria, Australia
William RenwickRecruiting - Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Paul CannellRecruiting
- A O Krankenhaus Der Elisabethinen
Linz, Austria
Irene StrasslRecruiting - Universitaetsklinikum St. Poelten
Sankt Pölten, Austria
Petra PichlerRecruiting - Krankenhaus Der Barmherzigen Schwestern Wien
Vienna, Austria
Eva Maria AutzingerRecruiting
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
Hugo ChapdelaineRecruiting
- Odense Universitetshospital
Odense, Denmark
Ida Bruun KristensenRecruiting
- Alexandra General Hospital of Athens
Athens, Greece
Meletios-Athanasios DimopoulosRecruiting
- Somogy Megyei Kaposi Mor Oktato Korhaz
Kaposvár, Hungary
Peter RajnicsRecruiting
- Azienda Ospedaliero-Universitaria Delle Marche; Sod Clinica Medica
Torrette, Italy
Massimo OffidaniRecruiting
- Amsterdam University Medical Center (amsterdam Umc)
Amsterdam, Netherlands
Niels Van de DonkRecruiting - St. Antonius Ziekenhuis
Nieuwegein, Netherlands
Inger NijhofRecruiting
- Aidport Sp. Z O.O.
Skorzewo, Poland
Michal KwiatekRecruiting
- Hospital Costa del Sol
Marbella, Spain
Maria CasanovaRecruiting - Hospital Universitari Son Espases (huse) (hospital Universitario Son Dureta) (husd)
Palma de Mallorca, Spain
Albert Perez MontanaRecruiting - Hospital Universitari I Politecnic la Fe
Valencia, Spain
Javier de la Rubia ComosRecruiting
- Gloucestershire Royal Hospital
Gloucester, Gloucestershire, United Kingdom
Asha JohnyRecruiting - Cardiff & Vale University Health Board
Cardiff, South Glamorgan, United Kingdom
Ceri BygraveRecruiting - County Hospital (stafford Hospital)
Stafford, United Kingdom
Kamaraj KarunanithiRecruiting
- Infirmary Health - Diagnostic & Medical Clinic (dmc)
Mobile, Alabama, United States
Furhan YunusRecruiting - Chao Family Comprehensive Cancer Center Uci
Orange, California, United States
Edward NelsonRecruiting - University of Kansas
Westwood, Kansas, United States
Jeries KortRecruiting - University of Maryland | Greenebaum Cancer Center
Baltimore, Maryland, United States
Mehmet KocogluRecruiting - Henry Ford Health System
Detroit, Michigan, United States
Philip KuriakoseRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Mark SchroederRecruiting - New York Oncology Hematology
Albany, New York, United States
Courtney Marie BellomoRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jan 2026
- Primary completion
- 11 Sept 2028
- Completion
- 11 Sept 2028
- Last update posted
- 18 May 2026
- Registered enrollment
- 183
- Registry id
- NCT06980480
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.